Final Results of a Multi-Institutional Phase I Clinical Trial of Afatinib in Combination with Docetaxel and Postoperative Radiation Therapy (PORT) for High-Risk Squamous Cell Carcinoma of the Head and Neck (SCCHN

Guilherme Rabinowits

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - 2017
Event2017 ASTRO annual meeting - San Diego, CA
Duration: Jan 1 2017 → …

Conference

Conference2017 ASTRO annual meeting
Period1/1/17 → …

Disciplines

  • Medicine and Health Sciences

Cite this